德克萨斯大学医学博士安德森癌症中心’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current clinical advances include combination therapies for thyroid cancer and multiple myeloma, as well as discoveries to improve CRISPR/Cas9 gene editing, to identify biomarkers for immunotherapy response, to utilize T cell therapy for...
In honor of their notable contributions to the field of cancer research, Juan Fueyo, M.D., and Victor Prieto, M.D., Ph.D., from The University...
德克萨斯大学医学博士Anderson癌症中心和Yingli Pharma US，Inc。今天宣布了一个战略联盟，以推动几种肿瘤学...
德克萨斯大学医学硕士安德森癌症中心和西北医学的科学家已经确定了在Covid-19患者血液中含有ACE2蛋白（EVACE2）的天然细胞外囊泡，这些蛋白质可以阻止在宝旋链细节研究中阻止广泛的SARS-COV-2病毒感染。。该研究今天发表在《自然传播》中。
The evACE2 act as decoys in the body and can serve as a therapeutic to be...
德克萨斯大学医学博士安德森癌症中心and Eisbach Bio GmbH today announced a strategic research collaboration to jointly discover...
德克萨斯大学医学博士安德森癌症中心’s Research Highlights provides a glimpse into recently published studies in basic, translational...
A blood test, combined with a risk model based on an individual’s history, more accurately determines who is likely to benefit from lung cancer...
在未治疗，晚期黑色素瘤的患者中，免疫检查点抑制剂Relatlimab和Nivolumab的组合使无进展的一倍增加...